Membership
Tour
Register
Log in
Thomas Francis Boucher
Follow
Person
Boston, MA, US
People
Overview
Industries
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Reducing junction epitope presentation for neoantigens
Patent number
11,885,815
Issue date
Jan 30, 2024
GRITSTONE BIO, INC.
Brendan Bulik-Sullivan
C40 - COMBINATORIAL CHEMISTRY
Information
Patent Grant
Neoantigen identification using hotspots
Patent number
11,264,117
Issue date
Mar 1, 2022
GRITSTONE BIO, INC.
Brendan Bulik-Sullivan
G01 - MEASURING TESTING
Patents Applications
last 30 patents
Information
Patent Application
REDUCING JUNCTION EPITOPE PRESENTATION FOR NEOANTIGENS
Publication number
20240361335
Publication date
Oct 31, 2024
Gritstone bio, Inc.
Brendan Bulik-Sullivan
C40 - COMBINATORIAL CHEMISTRY
Information
Patent Application
IDENTIFICATION OF NEOANTIGENS WITH MHC CLASS II MODEL
Publication number
20220154281
Publication date
May 19, 2022
Gritstone bio, Inc.
Thomas Francis Boucher
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
NEOANTIGEN IDENTIFICATION USING HOTSPOTS
Publication number
20220148681
Publication date
May 12, 2022
Gritstone bio, Inc.
Brendan Bulik-Sullivan
G06 - COMPUTING CALCULATING COUNTING
Information
Patent Application
Neoantigen Identification, Manufacture, and Use
Publication number
20210113673
Publication date
Apr 22, 2021
Thomas Boucher
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
REDUCING JUNCTION EPITOPE PRESENTATION FOR NEOANTIGENS
Publication number
20210011026
Publication date
Jan 14, 2021
Gritstone Oncology, Inc.
Brendan Bulik-Sullivan
C40 - COMBINATORIAL CHEMISTRY
Information
Patent Application
Neoantigen Identification with Pan-Allele Models
Publication number
20200411135
Publication date
Dec 31, 2020
Gritstone Oncology, Inc.
Thomas Francis Boucher
Information
Patent Application
NEOANTIGEN IDENTIFICATION USING HOTSPOTS
Publication number
20190279742
Publication date
Sep 12, 2019
GRITSTONE ONCOLOGY, INC.
Brendan Bulik-Sullivan